INDOUS
Start SIP
Invest Now
Start SIP in INDOUS
Performance
- Low
- ₹120
- High
- ₹124
- 52 Week Low
- ₹110
- 52 Week High
- ₹375
- Open Price₹124
- Previous Close₹122
- Volume14,540
Investment Returns
- Over 1 Month -2.1%
- Over 3 Month -11.75%
- Over 6 Month -18.39%
- Over 1 Year -57.14%
Smart Investing Starts Here Start SIP with Indo US Bio-Tech for Steady Growth!
Indo US Bio-Tech Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.
- P/E Ratio
- 14.7
- PEG Ratio
- 0.3
- Market Cap Cr
- 248
- P/B Ratio
- Average True Range
- 6.85
- EPS
- 8.43
- Dividend Yield
- 0
- MACD Signal
- -1.86
- RSI
- 43.68
- MFI
- 52.39
Indo US Bio-Tech Financials
Indo US Bio-Tech Technicals
EMA & SMA
Current Price
₹123.55
+
2.65
(2.19%)
- Bearish Moving Average 0
- Bullish Moving Average 0
- 20 Day
- ₹125.28
- 50 Day
- ₹129.71
- 100 Day
- ₹138.27
- 200 Day
- ₹156.53
Resistance and Support
121.58
- R3 126.27
- R2 124.93
- R1 122.92
- S1 119.57
- S2 118.23
- S3 116.22
Indo US Bio-Tech Corporate Actions - Bonus, Splits, Dividends
| Date | Purpose | Remarks |
|---|---|---|
| 2025-11-14 | Quarterly Results | |
| 2025-10-14 | Others | Inter-alia, to consider 1. Re-appointment of M/s. Gautam N Associates as a Statutory Auditors of the Company. 2. Approve Notice of Postal Ballot. 3. Other business matters. per share(2.5%)Interim Dividend |
| 2025-08-12 | Quarterly Results | |
| 2025-05-26 | Audited Results | |
| 2025-02-11 | Quarterly Results |
Indo US Bio-Tech F&O
About Indo US Bio-Tech
- NSE Symbol
- INDOUS
- BSE Symbol
- 541304
- Managing Director
- Mr. Jagdish Ajudia
- ISIN
- INE250Z01010
Similar Stocks to Indo US Bio-Tech
Indo US Bio-Tech FAQs
Indo US Bio-Tech share price is ₹123 As on 24 December, 2025 | 20:04
The Market Cap of Indo US Bio-Tech is ₹247.7 Cr As on 24 December, 2025 | 20:04
The P/E ratio of Indo US Bio-Tech is 14.7 As on 24 December, 2025 | 20:04
The PB ratio of Indo US Bio-Tech is 2.9 As on 24 December, 2025 | 20:04
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.